CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment, 21354-21355 [E8-8475]

Download as PDF 21354 Federal Register / Vol. 73, No. 77 / Monday, April 21, 2008 / Notices clinical personnel: Eighteen interviews from administrative personnel and twenty-three interviews from clinical personnel. The question set is the same for both clinical and administrative personnel. The estimated time per response is 1.5 hours for a total of 61.5 burden hours. Exhibit 2 shows the estimated annualized cost burden for the respondents’ time to provide the requested data. The hourly rate of $32.13 is a weighted average of the administrative personnel hourly wage of $19.68 and the clinical personnel hourly wage of $41.88. The total cost burden is $1,976. EXHIBIT 1.—ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Data collection Number of responses per respondent Hours per response Total burden hours In-person interviews ......................................................................................... 41 1 1.5 61.5 Total .......................................................................................................... 41 na na 61.5 EXHIBIT 2.—ESTIMATED ANNUALIZED COST BURDEN Number of respondents Data collection Total burden hours Average hourly wage rate* Total cost burden In-person interviews ......................................................................................... 41 61.5 $32.13 $1,976 Total .......................................................................................................... 41 na na 1,976 * Based upon the actual site personnel wages. Clinical personnel averages are weighted by the number of physicians, nurses and medical assistants in the sample. Administrative personnel averages are weighted by the number of administrators, lab, IT and other support personnel. Total average is weighted by relative number of administrative and clinical personnel being interviewed. Estimated Annual Costs to the Federal Government The total cost to the Federal Government for this project is $393,457 over a two-year period. The average annual cost is $196,728. The following is a breakdown of average annual costs: Direct Costs Personnel—$108,320 Consultancies—$24,400 Data support—$5,000 Travel—$2,575 Supplies—$100 IRB review—$125 Dated: April 11, 2008. Carolyn M. Clancy, Director. [FR Doc. E8–8444 Filed 4–18–08; 8:45 am] BILLING CODE 4160–90–M Indirect Costs Indirect costs (40%)—$56,208 DEPARTMENT OF HEALTH AND HUMAN SERVICES rwilkins on PROD1PC63 with NOTICES Request for Comments In accordance with the above-cited Paperwork Reduction Act legislation, comments on AHRQ’s information collection are requested with regard to any of the following: (a) Whether the proposed collection of information is necessary for the proper performance of AHRQ’s health care research and health care information dissemination functions, including whether the information will have practical utility; (b) the accuracy of AHRQ’s estimate of burden (including hours and costs) of the proposed collection(s) of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information upon the VerDate Aug<31>2005 16:59 Apr 18, 2008 respondents, including the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and included in the Agency’s subsequent request for OMB approval of the proposed information collection. All comments will become a matter of public record. Jkt 214001 Centers for Disease Control and Prevention (CDC) CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC and HRSA, announces the following meeting of the aforementioned committee: Times and Dates: 8 a.m.–5 p.m., May 20, 2008; 8 a.m.–12:30 p.m., May 21, 2008. Place: JW Marriott Buckhead, 3300 Lenox Road, Atlanta, Georgia 30326, Telephone (404) 262–3344, Fax (404) 262–8689. Status: Open to the public, limited only by the space available. The meeting room will accommodate approximately 100 people. PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 Purpose: This Committee is charged with advising the Director, CDC and the Administrator, HRSA, regarding activities related to prevention and control of HIV/ AIDS and other STDs, the support of health care services to persons living with HIV/ AIDS, and education of health professionals and the public about HIV/AIDS and other STDs. Matters To Be Discussed: Agenda items include issues pertaining to (1) Hepatitis C in the United States: Prevention, Surveillance, Treatment and Care Issues; (2) CDC Division of Sexual Transmitted Diseases Prevention, External Research Review Recommendations and Plans for Response; (3) Elimination of Health Disparities—CDC’s Heightened National Response and CDC’s Response to HIV/AIDS among African American Men Having Sex with Men; and (4) CDC’s New Integrated Partner Counseling and Referral Services Guidelines. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Margie Scott-Cseh, Committee Management Specialist, CDC, Strategic Business Unit, 1600 Clifton Road, NE., Mailstop E–07, Atlanta, Georgia 30333. Telephone (404) 639–8317, Fax (404) 639–8910. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. E:\FR\FM\21APN1.SGM 21APN1 Federal Register / Vol. 73, No. 77 / Monday, April 21, 2008 / Notices Dated: April 11, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–8475 Filed 4–18–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Establishment of a Community-Clinical Partnership for Primary Prevention of Type-2 Diabetes in Persons at High Risk, Potential Extramural Project (PEP) 2008–R–09 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. rwilkins on PROD1PC63 with NOTICES Time and Date: 1 p.m.–2:30 p.m., May 20, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Establishment of a Community-Clinical Partnership for Primary Prevention of Type-2 Diabetes in Persons at High Risk, PEP 2008–R–09.’’ Contact Person for More Information: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, Atlanta, GA 30333, Telephone (404) 498– 1194. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 10, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–8478 Filed 4–18–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Centers for Disease Control and Prevention Time and Date: 1 p.m.–2 p.m., May 14, 2007 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Preparing People with Arthritis to Safely Select and Self Direct their Physical Activity, PEP 2008–R–16.’’ Contact Person for More Information: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, Atlanta, GA 30333, Telephone (404) 498– 1194. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Evaluation of Environmental and Policy Interventions To Increase Fruit and Vegetable Intake, Potential Extramural Project (PEP) 2008–R–11 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 1 p.m.–3 p.m., May 29, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Evaluation of Environmental and Policy Interventions to Increase Fruit and Vegetable Intake, PEP 2008–R–11.’’ Contact Person for More Information: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, Atlanta, GA 30333, Telephone (404) 498– 1194. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 10, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–8480 Filed 4–18–08; 8:45 am] BILLING CODE 4163–18–P 16:59 Apr 18, 2008 Jkt 214001 Dated: April 10, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–8483 Filed 4–18–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2008–N–0189] (formerly Docket No. 2003N–0312) Meeting to Present Changes to the Animal Feed Safety System Project and the Ranking of Feed Hazards According to the Risks They Pose to Animal and Public Health; Part 3: Swine Feed Example; Public Meeting AGENCY: DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Preparing People With Arthritis To Safely Select and Self Direct Their Physical Activity, Potential Extramural Project (PEP) 2008–R–16 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act VerDate Aug<31>2005 21355 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 Food and Drug Administration, HHS. Notice of public meeting; request for comments. ACTION: SUMMARY: The Food and Drug Administration (FDA) is announcing the following public meeting: ‘‘Meeting to Present Changes to the Animal Feed Safety System (AFSS) Project and the Ranking of Feed Hazards According to the Risks They Pose to Animal and Public Health; Part 3: Swine Feed Example.’’ We are holding the public meeting in an effort to gather further information from you, our stakeholders, on changes to AFSS that will help E:\FR\FM\21APN1.SGM 21APN1

Agencies

[Federal Register Volume 73, Number 77 (Monday, April 21, 2008)]
[Notices]
[Pages 21354-21355]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-8475]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention (CDC)


CDC/HRSA Advisory Committee on HIV and STD Prevention and 
Treatment

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), CDC and HRSA, announces the following 
meeting of the aforementioned committee:

    Times and Dates: 8 a.m.-5 p.m., May 20, 2008; 8 a.m.-12:30 p.m., 
May 21, 2008.
    Place: JW Marriott Buckhead, 3300 Lenox Road, Atlanta, Georgia 
30326, Telephone (404) 262-3344, Fax (404) 262-8689.
    Status: Open to the public, limited only by the space available. 
The meeting room will accommodate approximately 100 people.
    Purpose: This Committee is charged with advising the Director, 
CDC and the Administrator, HRSA, regarding activities related to 
prevention and control of HIV/AIDS and other STDs, the support of 
health care services to persons living with HIV/AIDS, and education 
of health professionals and the public about HIV/AIDS and other 
STDs.
    Matters To Be Discussed: Agenda items include issues pertaining 
to (1) Hepatitis C in the United States: Prevention, Surveillance, 
Treatment and Care Issues; (2) CDC Division of Sexual Transmitted 
Diseases Prevention, External Research Review Recommendations and 
Plans for Response; (3) Elimination of Health Disparities--CDC's 
Heightened National Response and CDC's Response to HIV/AIDS among 
African American Men Having Sex with Men; and (4) CDC's New 
Integrated Partner Counseling and Referral Services Guidelines.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Margie Scott-Cseh, 
Committee Management Specialist, CDC, Strategic Business Unit, 1600 
Clifton Road, NE., Mailstop E-07, Atlanta, Georgia 30333. Telephone 
(404) 639-8317, Fax (404) 639-8910.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.


[[Page 21355]]


    Dated: April 11, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E8-8475 Filed 4-18-08; 8:45 am]
BILLING CODE 4163-18-P